Reduced expression of Krüppel-like factor 17 is related to tumor growth and poor prognosis in lung adenocarcinoma

Biochemical and Biophysical Research Communications

Volumn 418, Issue 1, 2012, Pages 67-73

  Cai, Xing dong ^a   Zhou, Yan bin ^a   Huang, Li xia ^a   Zeng, Qing li ^a   Zhang, Long juan ^a   Wang, Qin qin ^a   Li, Shao li ^a   Feng, Jian qiang ^b   Han, An jia ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Growth; KLF17; Lung adenocarcinoma; Prognosis

Indexed keywords

KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 17; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL COUNT; COLONY FORMATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; SURVIVAL PREDICTION; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; CELL PROLIFERATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84862826815     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.129     Document Type: Article

References (25)

1. Ahmedin J., Freddie B., Melissa M.C., et al. Global Cancer Statistics. CA CANCER J. CLIN. 2011, 61:69-90.
2. Malvezzi M., Arfé A., Bertuccio P., et al. European cancer mortality predictions for the year 2011. Ann. Oncol. 2011, 22:947-956.
3. Ahmedin J., Rebecca S., Jiaquan X., et al. Cancer Statistics, 2010. CA Cancer J. Clin. 2010, 60:277-300.
4. Wang N., Chen W.Q., Zhu W.X., et al. Incidence trends and pathological characteristics of lung cancer in urban Beijing during period of 1998 - 2007. Zhonghua Yu Fang Yi Xue Za Zhi 2011, 45:248-254.
5. Sagerup C.M., Smastuen M., Johannesen T.B., et al. Sex-specific trends in lung cancer incidence and survival: a population study of 40, 118 cases. Thorax 2011, 66:301-307.
6. Lam W.K., Watkins D.N. Lung cancer: future directions. Respiratory 2007, 12:471-477.
7. Suske G., Bruford E., Philipsen S. Mammalian SP/KLF transcription factors: Bring in the family. Genomics 2005, 85:551-556.
8. Jane van V., Linda A.C., Kate G.R.Q., et al. Human KLF17 is a new member of the Sp/KLF family of transcription factors. Genomics 2006, 87:474-482.
9. Black A.R., Black J.D., Azizkhan-Clifford J. Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell Physiol. 2001, 188:143-160.
10. Kazutoshi T., Koji T., Mari O., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
11. Wang X., Lu H., Urvalek A.M., et al. KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene 2011, 30:1901-1911.
12. Yu F., Li J., Chen H., et al. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 2011, 30:2161-2172.
13. Kaczynski J., Cook T., Urrutia R. Sp-and Krüppel-like transcription factors. Genome Biol. 2003, 4:206.
14. Lomberk G., Urrutia R. The family feud: turning off Sp1 by Sp1-like KLF proteins. Biochem. J. 2005, 392:1-11.
15. Zheng H.-Q., Zhou Z., Huang J., et al. Kruppellike factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1. Oncogene 2009, 28:3702-3713.
16. Henson B.J., Gollin S.M. Overexpression of KLF13 and FGFR3 in oral cancer cells. Cytogenet. Genome Res. 2010, 128:192-198.
17. Gumireddy K., Li A., Gimotty P.A., et al. KLF17 is a negative regulator of epithelial- mesenchymal transition and metastasis in breast cancer. Nat. Cell Biol. 2009, 11:1297-1304.
18. Iwanicki M.P., Brugge J.S. Transcriptional regulation of metastatic [Id] entity by KLF17. Genome Biol. 2009, 10:244.
19. Jun L., Nu Z., Li-Bing S., et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin. Cancer Res. 2008, 14:3319-3326.
20. WHO classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart 2004, IARC Press, Lyon. W.D. Travis, E. Brambilla, H.K. Müller-Hermelink, C.C. Harris (Eds.).
21. Genshi I., Mika U., Masashi K., et al. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells. Clin. Cancer Res. 2004, 64:3838-3843.
22. Goldstraw P (2009).International Association for the Study of Lung Cancer. Staging Manual in Thoracic Oncology. Orange Park, FL: RX Press Ed.
23. Yano T., Morodomi Y., Ito K., et al. Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification) from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size. J. Thorac. Oncol. 2010, 5:45-48.
24. Miyoshi K., Mimura T., Iwanaga K., et al. Surgical treatment of clinical n1 non-small cell lung cancer: ongoing controversy over diagnosis and prognosis. Surg. Today 2010, 40:428-432.
25. Wenxian H., WayneL H., Hong L., et al. Putative tumor-suppressor function of Krüppel-like factor 4 in primary lung carcinoma. Clin. Cancer Res. 2009, 15:5688-5695.